Needle injecting into the top of vaccine bottle

UK Government secures two million additional vaccine doses

As the UK Government continues to work to strike deals with manufacturers to secure additional doses of promising Covid-19 vaccine candidates, it has announced a further two million doses have been agreed.

The latest deal, which relates to doses of the Moderna vaccine candidate, brings the total number of secured doses for this particular vaccine to seven million – enough to potentially inoculate around 3.5 million people around the UK.

Before it can be approved for UK use, the vaccine must still meet the strict standards of safety and effectiveness of the independent medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).

If approval is achieved, the seven million secured doses could start to be delivered to the UK as early as Spring 2021 – the same timetable as with other European nations.

As part of its national Covid-19 vaccination strategy, the UK Government has worked to strike deals with a diverse portfolio of manufacturers of promising vaccine candidates. Across deals with seven different vaccine developers, the UK now currently has secured around 357 million vaccine doses.

Business Secretary Alok Sharma said: “It is essential that we continue to bolster our portfolio of vaccine candidates to ensure we’re in the best possible position to protect the public once we see that breakthrough.

“The UK was one of the first countries in Europe to sign a deal with Moderna, and I’m delighted we have been able to secure a further two million doses of their promising candidate for the British public.”

The vaccine candidate has, at present, shown itself to be one of the most promising candidates, with preliminary clinical trial results showing it to be nearly 95% effective in protecting against Covid-19, with no safety issues reportedly identified to date.

The safety data is still yet to be released by the manufacturer to show whether the vaccine is both safe and effective.

It is currently still conducting phase three clinical trials of the vaccine, which utilises mRNA vaccine technology.

NHE July/August 21

NHE July/August 21

Prioritising staff wellbeing

NHE’s July/August 2021 edition focuses on some of the key, defining aspects of a successful, supported health service: Mental Health & Workforce. Elsewhere, we take on the incredibly topical Infection Prevention and address the role which Pharma will play in both our NHS and wider health environment.


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Net-Zero NHS

As was outlined by Sir Simon Stevens when the NHS announced their green plans back in 2020, 5,700 lives could be saved each year by improved air quality. Even more could see their overall health improve and be in a position to self-manage their conditions, rather than requiring NHS treatment. Covid-19 has already left the NHS with a sizeable treatment backlog, so anything which can be done to improve patient health and reduce demand is beneficial for all.

Working together, we can help the NHS realise its green ambitions as per the Net-Zero National Health Service report and its ambitious 2040 target. Join us on August 25, 2021 for our Net-Zero NHS event, where we will be joined by health sector leaders and innovators for a day of sharing best practice and networking.

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all